Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease

Kayci Huff-Hardy, Mai Bedair, Rebecca Vazquez, Ezra Burstein

Research output: Contribution to journalLetter

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)E49
JournalInflammatory Bowel Diseases
Volume23
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Crohn Disease
vedolizumab
Ustekinumab

ASJC Scopus subject areas

  • Immunology and Allergy
  • Gastroenterology

Cite this

Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease. / Huff-Hardy, Kayci; Bedair, Mai; Vazquez, Rebecca; Burstein, Ezra.

In: Inflammatory Bowel Diseases, Vol. 23, No. 10, 01.10.2017, p. E49.

Research output: Contribution to journalLetter

@article{4dc67217cae34a56a23471bd3cf911c4,
title = "Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease",
author = "Kayci Huff-Hardy and Mai Bedair and Rebecca Vazquez and Ezra Burstein",
year = "2017",
month = "10",
day = "1",
doi = "10.1097/MIB.0000000000001232",
language = "English (US)",
volume = "23",
pages = "E49",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease

AU - Huff-Hardy, Kayci

AU - Bedair, Mai

AU - Vazquez, Rebecca

AU - Burstein, Ezra

PY - 2017/10/1

Y1 - 2017/10/1

UR - http://www.scopus.com/inward/record.url?scp=85029750172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029750172&partnerID=8YFLogxK

U2 - 10.1097/MIB.0000000000001232

DO - 10.1097/MIB.0000000000001232

M3 - Letter

C2 - 28858074

AN - SCOPUS:85029750172

VL - 23

SP - E49

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 10

ER -